BroadOak Capital Partners
Tim Johnson is an accomplished professional with extensive experience in leadership and finance. Currently serving as a Partner at BroadOak Capital Partners since February 2015, Tim also holds the position of Chief Executive Officer at Horizon Infusions and serves as a Board Member at Science and Medicine Group. Additionally, Tim is the Chairman of LabConnect and previously served as a Board Member at Pathology Inc. and as a Board Observer at DrugScan. Tim's experience includes being a General Partner at Mt. Weather Capital and Managing Director at England & Company. Early in Tim's career, experience was gained as an Audit Senior at Arthur Andersen & Co. Tim Johnson holds an MBA and a BS in Accounting, graduating Magna Cum Laude from the University of Maryland.
This person is not in the org chart
This person is not in any offices
BroadOak Capital Partners
BroadOak Capital Partners, with headquarters in Washington, DC, and San Francisco, is a life-sciences focused boutique financial institution that provides direct investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, and adjacent markets. BroadOak has led or participated in investments in more than fifty companies across multiple funds and investment vehicles.